Jan 25, 2023
1:20
For every 20 shares held, investors received 1. The price per share adjusted from $0.23 to $4.50.
The split itself did not change the total investment value.
Mayne Pharma Group Ltd. (ASX:MYX) operates in the Pharmaceuticals: major industry.
Mayne Pharma Group Ltd. company overviewMayne Pharma Group Ltd.'s most recent stock split was on January 25, 2023. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.
Mayne Pharma Group Ltd. (ASX:MYX) has split its stock 4 times: a 9-for-7 split on October 8, 2012, a 1029-for-1000 split on February 12, 2015, a 987-for-937 split on June 30, 2016, and a 1-for-20 reverse split on January 25, 2023.
Mayne Pharma Group Ltd. has split its stock 4 times. This history records 4 splits between October 8, 2012 and January 25, 2023.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Mayne Pharma Group Ltd.'s 1-for-20 reverse split on January 25, 2023, every 20 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Mayne Pharma Group Ltd. has not announced a new split in our records. Its most recent split was on January 25, 2023, 3 years ago. Companies announce splits in advance, and any new ASX:MYX split will appear on this page.
Already premium?